E Rn Financial, LLC Pfizer Inc Transaction History

E Rn Financial, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	SELL	$39.39 - $51.28 $4,451 - $5,794	-113 Reduced 2.21%	4,991 $203,000
Q4 2022 Feb 14, 2023	SELL	$41.75 - $54.5 $11,147 - $14,551	-267 Reduced 4.97%	5,104 $261,000
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $12,602 - $15,384	288 Added 5.67%	5,371 $235,000
Q2 2022 Aug 02, 2022	BUY	$46.53 - $55.17 $1,488 - $1,765	32 Added 0.63%	5,083 $267,000
Q1 2022 May 13, 2022	BUY	$45.75 - $56.69 $61,076 - $75,681	1,335 Added 35.93%	5,051 $261,000
Q4 2021 Feb 11, 2022	BUY	$41.32 - $61.25 $153,545 - $227,605	3,716 New	3,716 $219,000
Q2 2019 Aug 12, 2019	SELL	$36.98 - $41.52 $342,730 - $384,807	-9,268 Closed	0 $0
Q1 2019 Apr 18, 2019	BUY	$37.5 - $41.2 $347,550 - $381,841	9,268 New	9,268 $370,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of E Rn Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on E Rn Financial, LLC with notifications on news.